{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1047.379","meta":{"versionId":"17","lastUpdated":"2016-12-27T01:00:03.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.379","version":"20161227","name":"Moderate Emetic Risk Cancer Medication methotrexate","status":"active","date":"2016-12-27T01:00:03-05:00","publisher":"Oncology Nursing Society Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"6851","display":"Methotrexate"}]}]},"expansion":{"identifier":"urn:uuid:f7ea9444-8aff-48c2-b05f-1f47cab855cf","timestamp":"2022-06-10T09:50:22-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"6851","display":"methotrexate"}]}}